Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...

Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...

Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...

Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing ...

Cantor Fitzgerald adjusted its price target for Expedia Group Inc. (NASDAQ:EXPE) shares, bringing it down to $180 from the ...

Cantor Fitzgerald initiated coverage of Nice (NICE) with a Neutral rating and $176 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze ...

For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price target of $76.00. The company’s shares ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where Varonis Systems, Inc. (NASDAQ:VRNS) stands against the ...

Cantor Fitzgerald raised the firm’s price target on TripAdvisor (TRIP) to $14 from $11 and keeps an Underweight rating on the shares as part of a broader note on Internet Stocks. The fundamental ...